...
首页> 外文期刊>Molecular pharmaceutics >Design, Synthesis, and Biological Evaluation of 68 Ga-DOTA–PA1 for Lung Cancer: A Novel PET Tracer for Multiple Somatostatin Receptor Imaging
【24h】

Design, Synthesis, and Biological Evaluation of 68 Ga-DOTA–PA1 for Lung Cancer: A Novel PET Tracer for Multiple Somatostatin Receptor Imaging

机译:对肺癌68A-DotA-PA1的设计,合成和生物学评价:一种用于多生长抑素受体成像的新型PET示踪剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Most of the radiolabeled somatostatin analogues (SSAs) are specific for subtype somatostatin receptor 2 (SSTR_(2)). Lack of ligands targeting other subtypes of SSTRs, especially SSTR_(1,) SSTR_(3), and SSTR_(5), limited their applications in tumors of low SSTR_(2) expression, including lung tumor. In this study, we aimed to design and synthesize a positron emission tomography (PET) radiotracer targeting multi-subtypes of SSTRs for PET imaging. PA1 peptide and its conjugate with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) chelator or fluorescein isothiocyanate (FITC) at the N-terminal of the lysine position were synthesized. ~(68)Ga was chelated to DOTA–PA1 to obtain ~(68)Ga-DOTA–PA1 radiotracer. The stability, lipophilicity, binding affinity, and binding specificity of ~(68)Ga-DOTA–PA1 and FITC–PA1 were evaluated by various in vitro experiments. Micro-PET imaging of ~(68)Ga-DOTA–PA1 was performed in nude mice bearing A549 lung adenocarcinoma, as compared with ~(68)Ga-DOTA-(Tyr3)-octreotate (~(68)Ga-DOTA-TATE). Histological analysis of SSTR expression in A549 tumor tissues and human tumor tissues was conducted using immunofluorescence staining and immunohistochemical assay. ~(68)Ga-DOTA–PA1 had high radiochemical yield and radiochemical purity of over 95% and 99%, respectively. The radiotracer was stable in vitro in different buffers over a 2 h incubation period. Cell uptake of ~(68)Ga-DOTA–PA1 was 1.31-, 1.33-, and 1.90-fold that of ~(68)Ga-DOTA-TATE, which has high binding affinity only for SSTR_(2), after 2 h incubation in H520, PG, and A549 lung cancer cell lines, respectively. Micro-PET images of ~(68)Ga-DOTA–PA1 showed that the PET imaging signal correlated with the total expression of SSTRs, instead of SSTR_(2) only, which was measured by Western blotting and immunofluorescence analysis in mice bearing A549 tumors. In summary, a novel PET radiotracer, ~(68)Ga-DOTA–PA1, targeting multi-subtypes of SSTRs, was successfully synthesized and was confirmed to be useful for PET imaging. It may have potential as a noninvasive PET radiotracer for imaging SSTR-positive tumors.
机译:大多数放射性标记的生长抑素类似物(SSA)对于亚型生长抑制菌素受体2(SSTR_(2))是特异性的。缺乏靶向SSTR的其他亚型的配体,特别是SSTR_(1,)SSTR_(3)和SSTR_(5),限制了它们在低SSTR_(2)表达的肿瘤中的应用,包括肺肿瘤。在这项研究中,我们旨在设计和综合正电子发射断层扫描(PET)辐射游粉蛋白,瞄准SSTR的多次SSTR的宠物成像。合成PA1肽及其与1,4,7,10-四氮杂的癸烷-1,4,7,10-四乙酸(DOTA)螯合剂或荧光素异硫氰酸酯(FITC)的缀合物,在赖氨酸位置的N-末端被合成。 〜(68)Ga被螯合到Dota-Pa1以获得〜(68)Ga-dota-pa1放射性机构。通过各种体外实验评估〜(68)Ga-dota-pa1和FitC-PA1的稳定性,亲脂性,结合亲和力和结合特异性。与〜(68)Ga-dota-(Tyr3)相比,在携带A549肺腺癌的裸鼠中进行〜(68)Ga-dota-pa1的微宠物成像,与〜(68)-o-dota-(tyr3) - octreotate(〜(68)ga-dota-tate )。使用免疫荧光染色和免疫组织化学测定进行A549肿瘤组织和人肿瘤组织中SSTR表达的组织学分析。 〜(68)Ga-dota-pa1的放射性化产量高,放射化学纯度分别超过95%和99%。在2小时孵育期的不同缓冲剂中,放射性机构在体外稳定。 〜(68)Ga-dota-pa1的细胞吸收为1.31-,1.33-和1.90倍的〜(68)Ga-dota-tate,其仅在2小时后对SSTR_(2)具有高结合亲和力在H520,PG和A549肺癌细胞系中孵育。 〜(68)Ga-dota-pa1的微宠物图像表明,宠物成像信号与SSTR的总表达相关,代替SSTR_(2),其通过携带A549肿瘤的小鼠中的蛋白质印迹和免疫荧光分析来测量。 。总之,成功地合成了一种新型宠物放射反射器〜(68)GA-DOTA-PA1,靶向SSTR的多亚型,并确认可用于PET成像。它可能具有作为非侵入性宠物放射反射物的潜力,用于成像SSTR阳性肿瘤。

著录项

  • 来源
    《Molecular pharmaceutics》 |2018年第2期|共10页
  • 作者单位

    Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing);

    Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing);

    Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing);

    Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing);

    Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing);

    Department of Cancer Systems Imaging The University of Texas MD Anderson Cancer Center Houston;

    Department of Cancer Systems Imaging The University of Texas MD Anderson Cancer Center Houston;

    Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing);

    Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing);

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

    lung cancer; positron emission tomography imaging (PET); somatostatin analogues (SSAs); somatostatin receptors (SSTRs);

    机译:肺癌;正电子发射断层摄影成像(PET);生长抑素类似物(SSAS);生长抑素受体(SSTR);

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号